Synopsis:- Shares jumped up to 6% after securing a Rs 423 crore, four-year pharma supply contract for pen injectors. Operating profit rose from Rs 38 crore to Rs 64 crore, while OPM improved from 20% to 27%. Healthcare revenue surged 139%, driving growth despite a 13% decline in the consumer segment.
The shares of the prominent plastic component jumped up to 6 percent in today’s trading session after the company bagged a significant work order from a large domestic pharma company worth Rs 423 crores.
With a market capitalisation of Rs 9,222.04 crore, the shares of Shaily Engineering Plastics Ltd were trading at Rs 2,006.75 per share, increasing around 3.48 percent as compared to the previous closing price of Rs 1,939.30 apiece. Ashish Kacholia holds a 3.22 percent stake in the company.
Significant order
The shares of Shaily Engineering Plastics Ltd have seen positive movement after signing a Rs 423 crore manufacturing and commercial supply agreement with a large domestic pharma company for pen injectors. The four-year contract ensures long-term revenue visibility and strengthens its presence in the high-growth drug delivery segment, reinforcing its position as a key partner in the pharmaceutical supply chain.
The company reported a great improvement in Q3FY26 performance, with revenue rising 27% year-on-year to Rs 236 crore. More notably, net profit doubled to Rs 36 crore from Rs 18 crore, reflecting better margins and operating leverage. The sharp earnings growth highlights improved efficiency and stronger overall business momentum.
The segment mix shows a sharp shift in growth drivers. Consumer revenue declined 13% from 141.3 to 122.8, reflecting softer demand. In contrast, Healthcare surged 139% from 43.7 to 104.3, emerging as the key growth engine. Meanwhile, Industrial revenue jumped 87% from 12.5 to 23.4, indicating improving traction across diversified segments.
Between December 2024 and December 2025, the company delivered strong operating improvements. Operating profit rose from Rs 38 crore in Dec 2024 to Rs 64 crore in Dec 2025, reflecting better scale and cost efficiency. Meanwhile, OPM expanded from 20% to 27%, indicating healthier margins and improved operational discipline over the year.
The company operates seven state-of-the-art manufacturing facilities equipped with over 200 molding machines ranging from 35 to 1,000 tons. Located in Rania and Halol (GIDC), Gujarat, the plants cater to export-oriented units, pharma clean-room production, automotive engineering, carbon steel, and plastic segments, highlighting strong manufacturing scale and diversified capabilities.
Shaily Engineering Plastics Limited is a leading manufacturer of high-precision plastic components serving healthcare, consumer, and industrial sectors. Known for its strong engineering capabilities and advanced molding infrastructure, the company focuses on quality, innovation, and global partnerships, positioning itself as a reliable supplier in regulated and export-driven markets.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post Stock Jumps 3.5% After Bagging ₹423 Cr Order from a Large Pharma Company appeared first on Trade Brains.